Complement insufficiency limits efficacy in a xenograft model of hyperacute rejection for cancer therapy

Author: Larkin James   Porter Colin  

Publisher: Springer Publishing Company

ISSN: 0340-7004

Source: Cancer Immunology, Immunotherapy, Vol.56, Iss.1, 2007-01, pp. : 60-69

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content